Crashed From Peak Wall, Wall Street Bets on This Growth Stock
A growth stock that surged to lofty heights last year has cooled in 2026, but big buyers keep stepping in as AI capac...
Regularly reviewing your savings progress is essential for success. Discover effective methods to keep track of your financial journey.
20,681 articlesA growth stock that surged to lofty heights last year has cooled in 2026, but big buyers keep stepping in as AI capac...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Citigroup slashed its one-year targets for Bitcoin and Ethereum, citing a delayed U.S. policy timetable that dampens ...
Ford’s stock closed at its highest level in three years, powered by AI tie-ups, improving European margins, and robus...
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...
Investors paused on news from Middle East diplomacy talks, pushing the Nasdaq Composite lower as rates and energy mar...
Oil prices decline as investors weigh possible progress toward a Middle East peace agreement. Markets respond to dipl...
Billionaire investor Michael Burry has lodged a new tesla short bet, intensifying the debate over Tesla’s robotics pu...
IonQ faces a pivotal year as government and enterprise demand grows for quantum hardware and software. Analysts outli...
A Reagan Institute survey shows two-thirds of voters are upbeat on American-led innovation, spanning parties and gene...
Blue Origin is pursuing a $130 billion private-market valuation, signaling a bold push by jeff bezos’s space company ...